![LCPDFR Log File Error Instant Fix [STEAM] - Other ...](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_sqcmUVaPdfwV_JeiV3eKiep5-lfgGoGS4dKi5GDb-jPYzFtHGKdrLPof09wmPUQOnVSbMHcpB_84y9jaV5VRjY8IdkdokXpOI4hWPkb2XQhDfNdnI95e-tgcO0puXtv_sSqKu02AxWlRQ=w180)
KETK - Ramon Kumar, MD, treated a local patient at the Louis and Peaches Owen Heart Hospital at Trinity Mother Frances with a newly approved SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent from Boston Scientific making her the first patients in East to benefit from this highly anticipated new technology. The SYNERGY Stent was approved for use by the FDA on Oct. 5, 2015. Stents are tiny mesh tubes doctors use to prop open clogged arteries, allowing blood to flow freely to the heart.
“Bringing the most advanced medical technologies to our community directly supports our mission to provide outstanding patient care,” said Dr. Kumar. “Early adoption of the SYNERGY Stent, the first and only bioabsorbable polymer drug eluting stent in the U.S., reinforces our commitment to deliver advanced treatment to patients in East Texas and the surrounding communities.”
Manufactured by Boston Scientific, the SYNERGY Stent, with its bioabsorbable polymer, offers simultaneous drug and polymer absorption. Designed for faster healing, the SYNERGY Stent offers what you need when you need it; medicine, which inhibits coronary blockages from recurring, and freedom from permanent polymer exposure, which has been associated with complications such as vessel re-narrowing and blood clots.
“We are pleased to be working closely with Dr. Kumar and the Louis and Peaches Owen Heart Hospital at Trinity Mother Frances to ensure patients can access this innovative technology,” said Kevin Ballinger, President, Interventional Cardiology, Boston Scientific. “In development for over 10 years, the SYNERGY Stent reflects our commitment to bringing meaningful change to interventional cardiologists with the most complete portfolio of clinical solutions to best treat their patients,” said Ballinger. “We are excited to bring this transformative technology to U.S. facilities that provide best-in-class patient care.”
The SYNERGY Stent is being studied in more than 15,000 patients worldwide, and has documented outstanding safety and efficacy of the Bioabsorbable Polymer Everoliumus Eluting Platinum Chromium Stent. For images and video showing the SYNERGY stents unique properties please click here.
Dr.Kumar is a Trinitry Clinic Cardiologist with special expertise in interventional and endovascular therapies. He was trained at Harvard Medical School/Beth Israel Deaconess as well as the Texas Heart Insitute. He, his wife and two children live in Tyler and he is taking new patients.
TMF Performs First SYNERGY Stent Procedure in East Texas hospitals in nassau county | |
| 1 Likes | 1 Dislikes |
| 329 views views | 937 followers |
| Science & Technology | Upload TimePublished on 14 Jan 2016 |
Không có nhận xét nào:
Đăng nhận xét